| Term 
 | Definition 
 
        | CH 25 General Anesthetics Intravenous Anesthetics Barbiturates   
| Bind to GABAA receptor subunits facilitating Cl- channel opening; sedation and relief of anxiety   ↓ BP, SV, CO ↓ CNS metabolism, O2 utilization, cerebral blood flow ↓ Sensitivity of medullary respiratory center to CO2 (respiratory depressant) | Exacerbate porphyria   Respiratory depression, Induces P450 | Patients with cerebral swelling – head trauma, brain tumors (intracranial pressure not ↑) |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 25 General Anesthetics Intravenous Anesthetics   
|   Depression of central ventilator drive, transient  apnea, ↓ BP, negative ionotropic effects | Prolonged administration can ↑ serum lipid levels; severe acidosis in presence of resp infections and possible neurologic sequelae upon withdrawal (in children); pain at injection site, hypotonus, rarely tremors | Most popular IV anestheticmore rapid recovery, ↓ postop nausea and vomiting
   Induction and maintenance of anesthesia, and prolonged sedation |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 25 General Anesthetics Intravenous Anesthetics   
| Minimal cardiovascular and respiratory depression; rapid loss of consciousness with minimal hypotension, unchanged HR, low incidence of apnea | High incidence of pain on injection, myoclonic activity, postop nausea and vomiting, adrenocortical suppression  | Induction of anesthesia in patients with limited cardiovascular reserve No analgesic effects (administer with opioids) |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 25 General Anesthetics Intravenous Anesthetics   
| Blocks glutamate’s effects at the NMDA receptor   Stimulates the CNS Inhibits norepi reuptake   Anesthetic & analgesic with cardiovascular stimulation; ↑ HR, BP, CO, cerebral blood flow, O2 consumption, intracranial pressure | High incidence of post-op psychic phenomena: disorientation, sensory & perceptual illusions, vivid dreams   Psychosis | High-risk patients in cardiogenic or septic shock (due to cardio-stimulatory properties)   Produces a dissociative anesthetic state     |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 25 General Anesthetics Inhaled Anesthetics   
| Strong analgesia, cannot produce full anesthesia | Megaloblastic anemia |    
| Inhaled anesthetics target the GABAA receptor Cl- channel, which is a major mediator of inhibitory synaptic transmission. The anesthetics facilitate GABA-mediated inhibition, increasing the sensitivity of the GABAA receptor for GABA.   Other sites of action include stimulation of inhibitory glycine receptors in the spinal cord and inhibition of nicotinic receptors in the peripheral nervous system. | Acute Toxicity: Malignant hyperthermia   Chronic Toxicity: Prolonged exposure to most anesthetics can lead to renal insufficiency, mutagenicity, carcinogenicity, hematotoxicity, and a higher incidence of miscarriages |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 25 General Anesthetics Inhaled Anesthetics   
| Strong anesthetic; minor analgesia | Cardiac arrhythmias, severe Hepatic toxicity |  
|   |   |  
| Inhaled anesthetics target the GABAA receptor Cl- channel, which is a major mediator of inhibitory synaptic transmission. The anesthetics facilitate GABA-mediated inhibition, increasing the sensitivity of the GABAA receptor for GABA.   Other sites of action include stimulation of inhibitory glycine receptors in the spinal cord and inhibition of nicotinic receptors in the peripheral nervous system. | Acute Toxicity: Malignant hyperthermia   Chronic Toxicity: Prolonged exposure to most anesthetics can lead to renal insufficiency, mutagenicity, carcinogenicity, hematotoxicity, and a higher incidence of miscarriages |      |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 25 General Anesthetics Inhaled Anesthetics   
| Inhaled anesthetics target the GABAA receptor Cl- channel, which is a major mediator of inhibitory synaptic transmission. The anesthetics facilitate GABA-mediated inhibition, increasing the sensitivity of the GABAA receptor for GABA.   Other sites of action include stimulation of inhibitory glycine receptors in the spinal cord and inhibition of nicotinic receptors in the peripheral nervous system. | Acute Toxicity: Malignant hyperthermia   Chronic Toxicity: Prolonged exposure to most anesthetics can lead to renal insufficiency, mutagenicity, carcinogenicity, hematotoxicity, and a higher incidence of miscarriages |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 25 General Anesthetics Adjunct Drugs   
| Droperidol (a butyrophenone) and fentanyl administered together produce analgesia and amnesia and combinedwith nitrous oxide provide a state referred to as neuroleptanesthesia |   | Neuroleptanesthesia  |    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 25 General Anesthetics Adjunct Drugs (Opioid Analgesic) Opioid Side Effects: Histamine release, nausea   
| High doses used with benzodiazepines to achieve anesthetic state | Awareness during anesthesia and postop recall may occur; chest wall rigidity; ↑ postop opioid requirements due to tolerance | Cardiac or other major surgery when patient’s circulatory reserve is limited |  
   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CH 25 General Anesthetics Adjunct Drugs (Benzodiazepine) Benzodiazepine Side Effects: Diplopia, nystagmus   
| Bind to GABAA receptor subunits facilitating Cl- channel opening; sedation and relief of anxiety | Large doses prolong recovery period and can produce anterograde amnesia | Premedication – sedative-anxiolytic with high incidence of amnesia |    
 |  | 
        |  |